BioPharm America 2010 opened yesterday at the Copley Marriott in Boston, MA. We went to a fantastic session chaired by Reeve Brock of Harvard Stem Cell Institute on "Regenerative Medicine: Bridging the Gap between Science and Commercial Success".
The Life Science Leader Magazine recently ran a very interesting article entitled "Getting The Drug Repositioning Genie Out Of The Bottle", June 2010. Sistemic is previewed and CEO, Chris Hillier is quoted- check it out at http://www.lifescienceleader.com
GLASGOW, SCOTLAND Sistemic will be attending Phacilitate Cell & Gene Therapy World and the World Stem Cell Summit in January to highlight the development of their assay for assessment of pluripotent stem cell contamination in derived cell therapy products
Glasgow, SCOTLAND. Sistemic Ltd. is excited to announce significant progress with the development of a miRNA-based assay for assessment of pluripotent stem cell (PSC) contamination in derived cell therapy products. The development is being undertaken in conjunction with LGC, the UK National Measurement Laboratory and Designated Institute for chemical and bio-measurement.
Glasgow, Scotland Sistemic Ltd announced today the award of an Innovate UK grant to further develop, to a market-ready stage, its groundbreaking prototype microRNA-based assay for accurate assessment of pluripotent stem cell contamination in derived cell therapy products.